This round is no longer accepting investments, but others just like it are live now.

CLOSED

GET A PIECE OF PURACLENZ

Welcome to the Future of Clean.

Goodbye, viruses and mold. Hello to the future of clean. Puraclenz cleans indoor air and exposed surfaces in homes and businesses at the source. Our revolutionary, certified ozone-free PCO technology continuously deactivates dangerous pathogens, including mold spores, viruses, bacteria, fungal allergens, and odors. We’re a revenue-generating, air purification manufacturer and marketing company addressing the $11.6 billion interior air purification market.

Show more

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image

$135,560.16 Raised

REASONS TO INVEST

Reasons Icon

Revolutionary, Low Cost, and Patented Products - Our scientifically proven technology automatically destroys dangerous pathogens mid-air and on surfaces at the source

Reasons Icon

Massive, Flourishing Market - Puraclenz already has thousands of installations in the $11.6 billion air purification market projected to grow at a 10% CAGR

Reasons Icon

Experienced and Passionate Team - Previously generated millions in revenue and developed over 20 patent-to-market products

TEAM

Chris Dooley

Chris Dooley • CEO, Director & Co-Founder

Chris Dooley leads Puraclenz operations, product development, sales, marketing, finance and manufacturing. He is also a member of the company’s board of directors.

Chris is an accomplished senior executive, entrepreneur, and consultant with more than 25 years of success in SMART consumer product industries. He has held leadership positions with Marvel's toy division, Product Spring, Online Devices and iRobot. Chris led operations, U.S. sales, and marketing for iRobot’s Roomba launch and later established Roomba’s international distribution network in Europe, Canada, Russia, Korea, Japan, and Greater China. Chris is successful serial entrepreneur who has founded 5 startups, invented over 80 consumer products and 15 issued patents.

Chris has a Bachelor of Science in Mechanical Engineering from Villanova University and an MBA from New York University.

Read More

Wendell Minnick

Wendell Minnick • Executive Chairman & Co-Founder

Wendell Minnick co-manages company operations and marketing with Chris Dooley. He also has direct responsibility for investor relations and sales. Wendell is also a member of the company's board of directors.

Wendell has an extensive career as a founder, investor, and manager of early-stage companies in the energy/energy tech, materials science/nanotech, software systems, and direct consumer products industries. He has developed and commercialized advanced ceramic and nano-composite material technologies for military and commercial applications, raising more than $500 million in equity investments. His pre-seed investment in UVAIRx, Inc., enabled the advancement of photocatalytic oxidation (PCO) technology and the securing of a U.S. patent.

Wendell received a bachelor’s degree in Business from Principia College and completed MBA studies in International Economics at New York University and the London School of Economics.

Read More

Jerrod Keith

Jerrod Keith • Vice President of R&D

Jerrod Keith leads research and efficacy development of all Puraclenz products.

Jerrod spent 10 years as the head of research and development for UVAIRx, Inc., where he was responsible for designing and developing all UVAIRx air purification products. He oversaw UVAIRx products from initial concept design and 3D modeling, to rapid prototyping and patent protection, to design for manufacture and assembly, to product testing. He is the inventor of Puraclenz's reaction core system for the photocatalytic purifiers patent.

Jerrod earned his bachelor’s degree in Environmental Design (Architecture) from the University of Colorado Boulder.

Read More

Puraclenz Holdings, Inc. is the parent corporation of Puraclenz LLC, which is a wholly-owned subsidiary. Puraclenz LLC is the operating entity that was formed on June 25, 2020. The Company later formed Puraclenz Holdings, Inc. on December 29, 2021. All investors in this Reg CF offering will become shareholders of Puraclenz Holdings, Inc., which will be the sole member of Puraclenz LLC. The funds raised from this Reg CF offering and received by Puraclenz Holdings, Inc. will flow to Puraclenz LLC on an as-needed basis.

OVERVIEW


An air purifier redefining the standard of “clean air”

We’re not just another air purifier. Standard air cleaners only trap pathogens that pass through their filter… But us? We clean indoor air and surfaces at the source – destroying viruses, mold and bacteria - what we believe is the premier practice to clean air in today’s world.



Puraclenz provides continuous cleaning coverage with very low energy consumption and a 99% effective rate in eliminating airborne viruses and bacteria. We go beyond the limitations of current ionic purifiers. Our products generate no fumes or harmful chemicals and are certified ozone-free.

With a Puraclenz device, you’re treated like one of NASA’s esteemed astronauts. We use an evolved form of the same technology (photocatalytic oxidation) used to provide clean air to astronauts on the International Space Station. Our products clean the air you breathe using IP-protected innovations.


The last two years of the ongoing global health crisis have created a new need. People are seeking a cost-effective and automatic solution to destroy pathogens mid-air and on surfaces. 


It’s not enough to wear masks and wipe down surfaces anymore. Consumers need a product that raises the bar in technology, design, and price.



We’re currently selling five P-Series SKUs throughout North America, with distribution expanding to Europe, India, Southeast Asia, and Japan. In 2022, Puraclenz plans to introduce four new C-Series SKUs that combine our patented Next-Gen PCO technology with True HEPA. The result? What we believe is the most complete air purifier in the market. 


Model P1500 shown

the problem


Pathogens are too powerful for conventional air purifiers

We live in a world where pathogens dangerously disrupt every aspect of life. COVID-19 did and (continues to do) more damage than just getting people sick. Businesses closed. Graduations were canceled. Celebrations ruined. In the U.S. alone, there have been over 60 million Covid cases and over 829,000 Covid related deaths.


All types of pathogens, like viruses, bacteria, and mold, can cause major worldwide health issues. They are responsible for serious illnesses and infections, and even allergic reactions. Every year, 2.8 million bacterial infections occur in the U.S., and more than 35,000 people die. Up to 11% of people in the U.S. get the influenza flu annually. Even 93% of chronic sinus infections are attributed to mold. Excessive concentrations of bacteria, viruses, and molds can trigger asthma episodes for 15 million Americans.


 

People spend nearly 90% of their time indoors, and indoor air pollution is a top concern of the EPA. Typical indoor air contains two to five times more pollutants than outdoor air. 


Standard air purifiers clearly aren’t effective enough at destroying these pathogens. HEPA, a standard device, only collects particles that pass through its filter. Then, it uses air changes to clean pathogens in the room. 


These air changes take time. Ten to sixty minutes to be exact. By the time the cleaning is finished, people in the space could have already inhaled the pathogens.


the market


$11.6 billion air purification market with a 10% CAGR


Puraclenz is addressing the fast-growing $11.6 billion air purification market. It’s estimated to accelerate to $22.8 billion over the next six years, with a 10% CAGR. 


Source: Grand View Research


Industry analysts created those market estimates before COVID-19 started. We can only imagine the elevated market potential since the virus took off and developed its growing number of dangerous variants.   


Several companies and technologies compete with us in the Interior Air Quality (IAQ) sector. This sector uses various technologies, including UV light-based systems, hydrogen peroxide, negative ionizers, and more.


Most competitors’ products are considered “passive” devices, which have serious drawbacks:


  • Only treat air that passes through their device

  • Less energy-efficient

  • Regularly require expensive filters changes

  • Do not clean surfaces




There is a large price range for air purification. UV robots can cost $125,000 and small HEPA products cost $99.99. Our tech exceeds both competing capabilities at a price range between $299 and $499.


Our proprietary technology offers a unique market opportunity for powerful, low-cost, and certified safe air. We believe Puraclenz is the lowest cost professional-grade system. 

The company’s patent portfolio protects the advanced PCO design. We have four issued patents and six other pending patents. Plus our mass production process uses trade secrets that allow our purifiers to produce an extraordinarily high density of ions providing an unprecedented competitive advantage in the marketplace.

the solution


Complete air purification through small, inexpensive devices


Puraclenz provides continuous cleaning coverage in large areas with low energy consumption. And it’s easy too. Just plug in the unit, run continuously, and breathe easy knowing any pathogens are being destroyed at the source. 



We believe Puraclenz is the next generation of indoor air purification. Our devices use internal UV light that reflects onto a patented titanium catalyst, generating an extraordinarily high density of positive and negatively charged ions. These ions are the heroes–– they cling to and deactivate the pathogens mid-air and on exposed surfaces.


We now sell three purifier models that clean 750, 1,500, or 3,000 square feet areas. Since Puraclenz generates no fumes or harmful chemicals and is certified ozone-free, it’s safe to use around children and pets. Our lab studies also show, when Puraclenz is used in a room, it overwhelmingly halts the growth of mold. 


Puraclenz develops, manufactures, and markets its proprietary air purification products to businesses and consumers worldwide. In the U.S., we manage all marketing, sales, and customer support activities directly. We currently sell through three distribution channels.


PCO technology has been safely purifying the air and exposed surfaces for over 40 years. We advanced the power and safety of this technology with our patented cell design. Puraclenz’s design generates an extraordinarily high density of pathogen-destroying ions without producing any harmful by-products. Hand-cleaning or HEPA filters don’t cut it. Our design kills the pollutants they miss.




Why invest


Scientifically proven products with over $700,000 revenue and international distribution

Our numbers speak for themselves. Since we launched in May 2021, Puraclenz has already generated over $700,000 in revenue with thousands of installations. Many universities, luxury hotels, schools, fitness centers, grocery stores, and small businesses nationwide are using Puraclenz to clean their air and surfaces.


*Revenue of the company's subsidiary, Puraclenz, LLC.


We currently sell five SKUs through four distribution channels in the U.S., Canada, and Mexico. In the U.S., Puraclenz sells air purification equipment direct to home, business customers from Puraclenz.com, and in bulk through its team of sales reps and network of distributors. We have master distributor agreements for Canada and Mexico. 


Puraclenz has an aggressive five-year growth plan to address this accelerating market. We hope to see annual revenues of $200 million at the end.



In 2022, Puraclenz plans to introduce four more SKUs and expand worldwide distribution to Europe, Japan, India, Southeast Asia, and the Middle East. 


We project that U.S. distribution will also expand in the next two years. In 2022, Puraclenz hopes to expand distribution to online marketplaces like Amazon, Walmart.com, Rakuten, and Houzz. In 2023 and 2024, we aim that our products will be sold in home retail stores, such as Best Buy, Target, Bed Bath Beyond, Home Depot, Lowes, and more.



Global concerns of viral spread are growing. Every business and household needs better air purification. Our devices are scientifically proven to proactively reduce viruses mid-air and on exposed surfaces.  


We believe Puraclenz’s geographic, application, and technology segmentation offers a large growth potential in the air purification market. Our products are backed by a strong and experienced management team and protected by a global patent portfolio. 


This is your chance to participate in a market opportunity with disruptive technology. We’ve created a low-cost product that efficiently addresses what we feel is the biggest global health crisis in over 100 years. It feels good knowing we’re making a difference.


We’re so proud of our success with Puraclenz in just one year. Your investment will push us closer to our ambitious expansion goals in the years to come. Let’s protect people from pathogens and help them breathe easily. Join us!

ABOUT

HEADQUARTERS
P.O. Box 733
Old Greenwich, CT 06870
WEBSITE
View Site
Goodbye, viruses and mold. Hello to the future of clean. Puraclenz cleans indoor air and exposed surfaces in homes and businesses at the source. Our revolutionary, certified ozone-free PCO technology continuously deactivates dangerous pathogens, including mold spores, viruses, bacteria, fungal allergens, and odors. We’re a revenue-generating, air purification manufacturer and marketing company addressing the $11.6 billion interior air purification market.

TERMS

Puraclenz
Overview
PRICE PER SHARE
$8
DEADLINE
Jun. 8, 2022 at 6:59 AM UTC
VALUATION
$29.7M
FUNDING GOAL
$10K - $1.07M
Breakdown
MIN INVESTMENT
$248
MAX INVESTMENT
$1,070,000
MIN NUMBER OF SHARES OFFERED
1,250
MAX NUMBER OF SHARES OFFERED
133,750
OFFERING TYPE
Equity
SHARES OFFERED
Class B Non-Voting Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*

Early Bird

Friends and Family: Invest within the first 72 hours and receive 15% bonus shares.

Super Early Bird: Invest within the first week and receive 10% bonus shares.

Early Bird Bonus: Invest within the first 2 weeks and receive 5% bonus shares.

Volume

Invest $500+: Receive 30% off first purchase (up to $150 retail value)

Invest $1,000+: Receive 1 FREE P750 Purifier ($299 retail value)

Invest $5,000+: Receive 5% bonus shares + Receive 2 FREE Purifiers of your choice (up to $999 retail value)

Invest $10,000+: Receive 7% bonus shares + Receive 3 FREE Purifiers of your choice (up to $1,499 retail value)

Invest $25,000+: Receive 10% bonus shares + Receive 4 FREE Purifiers of your choice (up to $1,999 retail value)

Invest $50,000+: Receive 15% bonus shares + Receive 6 FREE Purifiers of your choice (up to $2,999 retail value)

Invest $100,000+: Receive 20% bonus shares + Receive 8 FREE Purifiers of your choice (up to $4,999 retail value)

*All perks occur when offering is complete.

The 10% StartEngine Owners' Bonus

Puraclenz Holdings, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class B Non-Voting Common Stock at $8.00 / share, you will receive 10 additional shares of Class B Non-Voting Common Stock, meaning you'll own 110 shares for $800. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Insider Investment Notice

Officers, directors, executives, and existing owners with a controlling stake in the company (or their immediate family members) may make investments in this offering. Any such investments will be included in the raised amount reflected on the campaign page.

Irregular Use of Proceeds

Example - The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments and salary made to one's self, a friend or relative; Any expense labeled "Administration Expenses" that is not strictly for administrative purposes; Any expense labeled "Travel and Entertainment"; Any expense that is for the purposes of inter-company debt or back payments.

PRESS

Article Image
Associated Press

Tech Startup Puraclenz™ Launches Powerful Next-Gen Air Purifiers Proven To Proactively Destroy Viruses Mid-Air With Patented “Ozone Free” Ionization Technology

Article Image
Treadhunter

The Puraclenz Air Purifier is Effective Against Bacteria

Article Image
Yahoo! Finance

Tech Startup Puraclenz™ Launches Powerful Next-Gen Air Purifiers Proven To Proactively Destroy Viruses Mid-Air With Patented "Ozone Free" Ionization Technology

Article Image
Vogue

Breathe Easy With These Air Purifiers

ALL UPDATES

06.07.22

Last Day to Invest: 4 Ways Puraclenz is Changing the Air Purification Industry

The air we breathe is constantly teeming with various microbes, which are harmless. However, certain airborne pathogens can pose a serious threat to human health, particularly for those with weakened immune systems. According to research, up to 93% of chronic sinus infections are attributed to mold, while bacteria and viruses are responsible for triggering asthma episodes in an estimated 15 million Americans. In addition, the flu virus is estimated to cause up to 11% of all respiratory infections in the United States each year.
In today's world, we are constantly bombarded by various pollutants, both inside and outside our homes and workplaces. So, it's essential to keep the air we breathe at the best quality we can. Fortunately, there are several ways to improve the air quality in our homes and workplaces, but many still have flaws and aren't as effective as they should be. Enter Puraclenz. Its patented core technology offers a low-cost air and surface purifier certified to be ozone-free and safe for humans and pets; proven highly effective by multiple independent laboratory tests in combating dangerous viruses, bacteria, and mold including SARS-CoV-2, the virus that causes COVID-19. Puraclenz wants consumers to feel confident that Puraclenz has helped them provide healthier interior air and surfaces in their homes and workplace.
So what sets Puraclenz apart from its competitors? Here are four reasons Puraclenz is the future of clean:

  1. Next-generation tech. Puraclenz uses a unique photocatalytic oxidation method (PCO) to improve air quality indoors at the International Space Station. The Puraclenz device eliminates viruses, bacteria, mold, fungal allergens, and other harmful pathogens found in the air and on exposed surfaces.  
  2. Continuously on, 24/7. Over 40 years of PCO technology have been used for purifying air and surfaces in numerous commercial applications. Our patented cell design has advanced PCO technology to be more powerful and certified safe by independent laboratories. By using ozone-free ions, Puraclenz deactivates indoor pollutants without producing harmful byproducts. 
  3. Puraclenz is scientifically proven. Independently conducted efficacy tests confirm that Puraclenz dynamically destroys mold mid-air and on exposed surfaces, continuously cleaning throughout a typical indoor space 24/7. Puraclenz P3000 units have been proven to be more than 99.7% effective at reducing airborne, methicillin-resistant Staphylococcus epidermidis (MSRE). MSRE is an FDA-recognized substitute for MRSA, strep pneumonia, and strep pyogenes, bacterial agents responsible for many difficult-to-treat and deadly infections.
  4. A passionate, forward-thinking team. In an effective, safe-to-use, and affordable way, Puraclenz is preventing dangerous viruses, mold, and bacteria from infiltrating indoor air and on surfaces, so people worldwide can breathe easier.
Excited about Puraclenz's innovative air purification solution? Learn more and become an early investor today by joining their equity crowdfunding campaign at https://www.startengine.com/puraclenz.


Invest Now in Puraclenz

06.06.22

Puraclenz Campaign Ends Tomorrow June 7 at 11:59pm PST

Puraclenz®, maker of professional air and surface purifiers that are low-cost and highly effective against dangerous viruses, bacteria, and mold, including SARS-CoV-2, the virus that causes COVID-19, is ending its Regulation Crowdfunding Campaign tomorrow June 7, 2022 at 11:59pm PST.

In addition to enhancing interior air quality, Puraclenz® comes with no chemicals or other additives, making it a low-cost yet effective solution. Puraclenz's founders developed the technology long before the global pandemic, proven to safely reduce viruses and bacteria that thrive in today's conditions. Based on independent efficacy tests, Puraclenz® P3000 is over 99% effective against the MS2 (the proxy virus of SARS-CoV-2) in the air. In a separate lab test, a Puraclenz® P3000 deactivated 95.4% of dangerous bacteria such as MRSA (Methicillin-Resistant Staphylococcus Aureus).

In the future, interior air purification will look much different than it does today with Puraclenz's patented technology. With its revolutionary natural ionization process, the company redefines how we clean and sanitize spaces, creating high-density ions without generating ozone or using harmful chemicals that can be toxic over time, even in small doses. In both large and small public areas such as restaurants, churches, spas, gyms, homes, waiting rooms, and more, Puraclenz fills spaces with natural ions that proactively kill pathogens in the air around them and on exposed surfaces.

"We're excited to offer a low purchase price and low maintenance cost air purification solution to a much larger audience with the help of our new investor partners," says CEO Chris Dooley.  

Businesses can reduce their dependence on spray disinfectants by using Puraclenz and saving time and money. This innovation significantly speeds up the reopening process, provides workers with a more comfortable and secure office work environment, and enables customers to use indoor services, such as gyms or spas, where they might feel uneasy following two years.

For more information, visit https://www.startengine.com/puraclenz.

About Puraclenz: Puraclenz is a company focused on health, wellness, and technology. It has reinvented in-flight air purification using PCO (photocatalytic oxidation) technology previously used to purify the air in the International Space Station. Using their proprietary version of this technology, Puraclenz developed a line of powerful, affordable, and certified ozone-free air purifiers to help businesses reopen quickly. The Puraclenz team is motivated by personal experience and science and founded on their own proprietary technology. Puraclenz's mission is to offer consumers low-priced, high-performance interior air and surface purification products for home and the workplace. In addition to a competitive purchase price and low maintenance cost, they also provide a large area of coverage substantially proven effective in multiple independent laboratory tests against dangerous viruses, bacteria, and mold.

06.02.22

Puraclenz is proven over 99% effective against mold spores on surfaces

New laboratory test results are in! World renown laboratory Eurofins in France conducted a surface test following EN 17272 standards that show a Puraclenz P3000 unit reduced Candida albicans mold by 99.75% inside a large 34.5m3 test chamber. Plates with the live mold spores were placed over 8 feet away from the P3000 device during this test and the Puraclenz unit remotely reduced the pathogen by 99.75% over an 8 hour period. 

Ordinary air purifiers cannot destroy pathogens on surfaces like Puraclenz. Get info on investing in Puraclenz: www.startengine.com/puraclenz


Puraclenz proven 99% effective against mold spores on surfaces


Invest now in Puraclenz


05.31.22

Cumulative Revenue Reaches $1 Million

Puraclenz's cumulative booked revenue is now over $1 million including purchase orders received. 


Get info on investing in Puraclenz: www.startengine.com/puraclenz


Puraclenz $1 million Cumulative Revenue Reached


Invest Now in Puraclenz

04.13.22

USA Registered Trademark Granted

Puraclenz is pleased to announce that the United States Patent and Trademark Office

 has granted a registered trademark for PURACLENZ


Get info on investing in Puraclenz: www.startengine.com/puraclenz 

USA Registered Trademark Granted for PURACLENZ

This important trademark joins the growing intellectual property portfolio owned by Puraclenz summarized below: 

  • Utility Patents protecting Puraclenz’s proprietary cell design that allows our products to generate the highest density of ozone free, photocatalytic oxidation ions in the marketplace: 
    • Issued Patents: USA, Japan, China, Macau (click here for the list) 
    • Pending Patents: India, Canada, Korea, UAE, European Patent Organization.  
  • Pending Design Patents protecting Puraclenz’s P-Series outside shape and proprietary Top Cover design: USA, Hague design application for EU, Switzerland, UK, Canada, Korea and Japan. 
  • Trademarks for PURACLENZ: 
    • USA registered trademark 
    • Mexico registered trademark 
    • Pending Canada trademark 
  • Trade Secrets – Proprietary coating formulation and manufacturing techniques that provide an unprecedented competitive advantage and ensure Puraclenz remains the most technologically advanced PCO air and surface purification design available in the marketplace.  

Invest Now in Puraclenz 

04.07.22

$87k Purchase Order Received from Canadian Distributor

Canada Sales are Scaling Up. Puraclenz’s Canadian master distributor Ogena Solutions has issued a new $87,998 purchase order and also provided a forecast to purchase an additional $280,000 in 2022. Sales in Canada began in January 2022 and Ogena Solutions has made great distribution progress in just several months.

Ogena Solutions. In 2021, Puraclenz entered into an exclusive master distribution agreement with Ogena Solutions to sell our commercial line of products in Canada and to USA Animal Health customers. Ogena Solutions has forged an identity as one of the most respected animal health biosecurity companies in North America and over the last several years has been expanding its knowledge and experience into the human health sector. Following a ‘One Health’ philosophy, Ogena Solutions offers innovative, state-of-the-art products and technologies that meet the highest standards for efficacy, efficiency, and safety, providing best-in-class solutions for government agencies, corporations, and small businesses throughout the continent.

Get info on investing in Puraclenz: www.startengine.com/puraclenz

Puraclenz Canada Sales are Scaling Up

Invest Now in Puraclenz

03.31.22

Insider Investment Notice

Puraclenz has an investment update. Insiders made investments in the amount of $10,496 in the Company’s current Reg CF offering. Please refer to the offering materials for further information and refer to the Company’s Risk Factors.

03.30.22

New Supply Chain Agreement Saves 25%

As part of the Company’s major effort to reduce its cost of goods sold and maintain our lowest professional grade pricing model, Puraclenz is moving mass production of its P-series products to Vietnam. 

This will reduce Puraclenz's manufacturing costs by 25% for every P-series product imported into the USA by eliminating the Section 301 tariff and leveraging lower labor costs in Vietnam. Our CEO Chris Dooley has worked with the owners of our new manufacturer for over 20 years. They are a seasoned and trusted supplier to many Fortune 500 companies. The new Manufacturing Agreement was signed on March 25, 2022 and mass production in Vietnam will start before the end of 2022.

 Get info on investing in Puraclenz: www.startengine.com/puraclenz 

Puraclenz is the lowest cost professional grade system


Invest Now in Puraclenz
 



 


03.25.22

Cumulative Revenue Reaches $885k and 3 New Distributors Signed

Puraclenz continues its strong revenue growth. Puraclenz's cumulative booked revenue is now over $885,000 including purchase orders received. The Company currently sells 5 SKU's through 4 channels of distribution in the USA, Canada and Mexico. In the USA, Puraclenz sells air purification equipment direct to home and business customers from Puraclenz.com, and in bulk through its team of sales reps and network of distributors.

Puraclenz’s network of authorized distributors is expanding. In the past month, Puraclenz has signed distribution agreements with 3 new distributors in California, North Carolina and Florida who are selling our products to their commercial clients including health care practitioners, municipal government agencies, non-profit organizations, and office space. 

 

Get info on investing in Puraclenz: www.startengine.com/puraclenz 

Puraclenz reaches $885k cumulative revenue

Invest Now in Puraclenz 

03.18.22

We've reached the $100k Milestone

Our entire team is grateful for the tremendous support to all who have invested in our company thus far! There has been incredible momentum behind the campaign and at the moment of this message we have raised over $100k in investments in just over 1 week!



We will be posting updates here at least once per week to keep you apprised of all of the exciting new developments. You can also join the mailing list on our website and stay in touch on Facebook and Instagram.


REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign reward.
Venture Club

Venture Club

Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).

$500

Tier 1

Invest $500+: Receive 30% off first purchase (up to $150 retail value)

$1,000

Tier 2

Invest $1,000+: Receive 1 FREE P750 Purifier ($299 retail value)

$5,000

Tier 3

Invest $5,000+: Receive 5% bonus shares + Receive 2 FREE Purifiers of your choice (up to $999 retail value)

$10,000

Tier 4

Invest $10,000+: Receive 7% bonus shares + Receive 3 FREE Purifiers of your choice (up to $1,499 retail value)

$25,000

Tier 5

Invest $25,000+: Receive 10% bonus shares + Receive 4 FREE Purifiers of your choice (up to $1,999 retail value)

$50,000

Tier 6

Invest $50,000+: Receive 15% bonus shares +Receive 6 FREE Purifiers of your choice (up to $2,999 retail value)

$100,000

Tier 7

Invest $100,000+: Receive 20% bonus shares + Receive 8 FREE Purifiers of your choice (up to $4,999 retail value)

JOIN THE DISCUSSION

0/2500

PINNED BY STARTUP

DH
Dave Hachey

3 years ago

My company (www.ogenasolutions.com) has been focused in the biosecurity space for over 17 years and is a well respected provider of biosecurity supplies, protocols and training in animal health. Three years ago we found the people at Puraclenz, have invested in them, and have the following thoughts on HEPA: Although HEPA filters are very good they're definitely not as effective as people are led to believe. Most believe that HEPA filters remove 99.97% of bacteria in an entire room, when in fact that rating is only a measurement of what comes out of the clean side of the filter. The reality is that the 99.97% rating is NOT what a HEPA filter will do for all the air in an average room. If the room is specifically designed for the use of HEPA filters, such as a surgical suite in a hospital where everything, the heating/cooling system, the shape of the room, the placement of the equipment, everything, is designed to ensure that ALL of the air in the room goes through the HEPA filter about 12-20 times/hour, THEN you may achieve 99.97% for the entire room. Unfortunately the spaces we live and work in are not designed for HEPA and do not have anywhere near that number of air changes per hour of all the air in a room (average heating/cooling systems provide 1-2 ACH), and depending on the size of the HEPA system you may get up to 6 ACH. According to ASHRAE (https://www.ashrae.org/), the organization that develops the indoor air quality standards used by the EPA, a properly sized HEPA system placed in the average indoor space will only capture about 50% of the 'particulate' matter (not specifically viruses or bacteria) in the room. To me, this is why we need more, why despite all the measures we take diseases still spread. The EPA has labelled PCO as an 'emerging technology' because although it's been known to be very effective at killing viruses, bacteria and mold, the thing that's held it back from widespread use is that PCO devices have generated unsafe levels of ozone and shouldn't be used around people and animals. The Puraclenz invention is that they've found a way to create a system that increases the level of ions in the air without the use or development of ozone (All Puraclenz systems passed the UL2998 certification test for being an ozone free device). To us, this is one of the biggest breakthrough's in air purification technology in decades, and the bonus is that the ions work on surfaces as well.

Show more

1

0

MN
Michael Nadler

3 years ago

Late question sorry- you market to residential customers through your digital marketing campaign. I can't find you guys on internet unless you specifically type in puraclenz. What specifically is the strategy to market to consumers? Is the digital paid marketing i.e. scrolling on instagram and see an ad because you searched or clicked on something similarly speaking? Which market is the bigger market for you- consumer or businesses? There's competition and am struggling to understand future opportunity and competition if the consumer can't find you online for example.

Show more

1

0

MN
Michael Nadler

3 years ago

Is your target market consumers or businesses/enterprises? I believe consumers is where your opportunity is primarily? Although I see all the benefits in the product/company and have no hesitations against your pitch or answers to my questions, as an investor I am struggling to make an investment. I am more so contemplating buying one for myself- the p750.

Show more

2

0

JB
James Bondulich

3 years ago

Hello Chris, a few weeks ago you were good enough to provide an update on revenue through February. Is it now possible to get an update on March, April and when known May. I've invested in Puraclenz because of the quality of its product. However it is the sales that makes the company worth its valuation. If sales continued to be good in March and April, it would help me add to my investment before the offering ends in a few days. Thanks.

Show more

1

0

MN
Michael Nadler

3 years ago

What's it about the team that you can execute on this and what's special about the patents meaning what do they protect exactly? Are you looking to be acquired in x number of years since I doubt you're looking to ipo?

Show more

1

0

MN
Michael Nadler

3 years ago

What's your rational for defending a 1.3 mil loss in your latest fiscal year and a 30 mil valuation? Talk to me about the companies growth rates that will hopefully accompany a 30 mil valuation. Lastly, Puraclenz's don't have filters/don't need to be changed, and if so, is this because of the technology within the devices themselves?

Show more

2

0

RM
Richard Mangi

3 years ago

I've was fortunate to have an opportunity to review Puraclenz scientific data. It's an extremely impressive advance on all the other air filters on the market. Not only am I an investor, but I also recommend Puraclenz to my patients, particularly those with mold contamination in their home. Moreover, I have a unit in my office to help protect my patients, my staff and myself from Covid-19, influenza and common cold viruses. Richard M., M.D.

Show more

0

0

CC
Christian Camargo

3 years ago

This tech works plain and simple. Me and eight other friends are hooked based on researching the science and testing it out. My trainer uses two to clean his gym. I'm not an experienced investor but Ive not seen anything like this on the market. It's a game changer for small business that can't afford the upgrades to their HVAC. My son gets sick every week in daycare. I'm installing one at his school as we speak. Corona is here to stay so we need state of the art filtration to combat the reality. In my opinion this company needs the push to get over the edge of others who only care about design and marketing.

Show more

1

0

KV
Kumar Vadhri

3 years ago

The product is very interesting. Can you please mention the current monthly revenues(appx 100k?) and monthly run rate(expenses). How many months of runway would you have?

Show more

1

0

MN
Michael Nadler

3 years ago

Interested and curious because air purifiers work. More homes/businesses/etc could really benefit from air purification systems for many reason, but why is puraclenz better? Is the proven effectiveness better with puraclenz versus competitors? i.e. you say 99% over 99% for viruses and bacteria's and 95% for mold. Why is mold 95% efficacy as opposed to 99%? Do air purifiers on the market not treat/protect against pathogens? If they do, then who are your top competitors on the market? If pco technology has been around for many years, how are you doing it better/what's unique about puraclenz? Don't mean to be repetitive, but looking for a comprehensive answer. Thanks.

Show more

1

1

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

FAQ Timeline

WHY STARTENGINE?

Rewards Icon
REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

Lock Icon
SECURE

Your info is your info. We take pride in keeping it that way!

Ellipse Icon
DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

RAISED
$135,560.16
INVESTORS
74
MIN INVEST
$248
VALUATION
$29.7M

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of primary offerings:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (“ATS”) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies who have engaged StartEngine Secure LLC as their transfer agent. The term “Rapid,” when used in relation to transactions on SE Marketplace, specifically refers to transactions that are facilitated on SE Secondary, This is because, unlike with trades on the StartEngine Bulletin Board (“SE BB”), trades on SE Secondary are executed the moment that they are matched.

StartEngine Bulletin Board (“SE BB”) is a bulletin board platform on which users can indicate to each other their interest to buy or sell shares of private companies that previously executed Reg CF or Reg A offerings not necessarily through SE Primary. As a bulletin board platform, SE BB provides a venue for investors to access information about such private company offerings and connect with potential sellers. All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed. Even if parties express mutual interest to enter into a trade on SE BB, a trade will not immediately result because execution is subject to additional contingencies, including among others, effecting of the transfer of the shares from the potential seller to the potential buyer by the issuer and/or transfer agent. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. By contrast, under SE BB, SE Primary assists with the facilitation of a potential resulting trade off platform including, by among other things, approaching the issuer and other necessary parties in relation to the potential transaction. The term “Extended”, when used in relation to transactions on SE Marketplace denotes that these transactions are conducted via SE BB, and that these transactions may involve longer processing times compared to SE Secondary for the above-stated reasons.

Even if a security is qualified to be displayed on SE Marketplace, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an endorsement, solicitation or recommendation by StartEngine. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.